Skip to content
WorkingMomRx
Menu

Head-to-head

CoreAge Rx vs NewSelf

CoreAge Rx and NewSelf both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.

CoreAge Rx

Higher score

Ranked #1 · Grade A

Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.

Visit CoreAge Rx
vs

NewSelf

Ranked #22 · Grade C

Best for: Working moms who want a genuinely flat price that never climbs as their dose increases, and are comfortable prepaying 3 months.

Visit NewSelf

The verdict

Higher Rx-Readiness Score: CoreAge Rx

CoreAge Rx edges out NewSelf on the Rx-Readiness Score, 95 to 70 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.

NewSelf is still a genuine option — a flat, dose-independent price for both molecules — $99.97/mo semaglutide, $144.49/mo tirzepatide, same price at every dose — nationwide, though it requires 3 months upfront. Weigh the six readiness factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.

CoreAge Rx NewSelf
Time to first dose9578
CoreAge
NewSelf
Flat, predictable pricing9782
CoreAge
NewSelf
No-video (async) intake9555
CoreAge
NewSelf
Nationwide access9688
CoreAge
NewSelf
Both molecules on one plan9560
CoreAge
NewSelf
Easy off-ramp9245
CoreAge
NewSelf

Price, access & features

DetailCoreAge RxNewSelf
Rx-Readiness Score95/100 · A70/100 · C
Overall rank#1#22
Semaglutide$99/mo$99.97/mo
Tirzepatide$149/mo$144.49/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

CoreAge Rx

Ranked #1 · Grade A

What we like

  • Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
  • Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
  • Async, no-video intake and all-50-states coverage — start it during a lunch break

The caveats

  • Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
  • Compounded only — no FDA-approved brand option
  • General metabolic program, not a boutique concierge service

NewSelf

Ranked #22 · Grade C

What we like

  • Explicitly flat, dose-independent pricing for both molecules — a real differentiator most competitors don't offer
  • Nationwide (all 50 states)
  • Fast: signup to treatment in as little as 4 days, per the site

The caveats

  • Requires 3 months upfront rather than a true month-to-month option
  • No named compounding pharmacy or medical director found on the pages checked
  • No brand-name (FDA-approved) option and no oral form

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing CoreAge Rx and NewSelf against other providers on our shortlist.

Or browse the full comparison hub.